Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/29/2871256/0/en/GRI-Bio-Announces-Abstracts-Accepted-for-Presentation-at-the-14th-International-Congress-on-Autoimmunity.html
https://www.globenewswire.com/news-release/2024/04/25/2869721/0/en/GRI-Bio-to-Present-at-LIVE-with-Webull-Corporate-Connect-Virtual-Biotech-Investment-Webinar.html
https://www.globenewswire.com/news-release/2024/04/16/2863622/0/en/GRI-Bio-Expands-Intellectual-Property-Protection-for-Proprietary-Natural-Killer-T-NKT-Cell-Modulators-with-Issuance-of-Korea-Patent.html
https://www.globenewswire.com/news-release/2024/04/08/2859198/0/en/GRI-Bio-Announces-Abstract-Accepted-for-Poster-Presentation-at-the-2024-American-Thoracic-Society-International-Conference.html
https://www.globenewswire.com/news-release/2024/04/01/2855105/0/en/GRI-Bio-Reports-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/03/28/2854051/0/en/GRI-Bio-to-Present-at-the-MedInvest-Biotech-Pharma-Investor-Conference.html
https://www.globenewswire.com//news-release/2024/03/14/2846287/0/en/GRI-Bio-Announces-Notice-of-Allowance-for-Canadian-Patent-Covering-Proprietary-Natural-Killer-T-NKT-Cell-Modulators.html
https://www.globenewswire.com//news-release/2024/03/04/2839590/0/en/GRI-Bio-Receives-MHRA-Authorization-to-Conduct-Phase-2a-Biomarker-Study-Evaluating-GRI-0621-in-the-United-Kingdom.html
https://www.globenewswire.com//news-release/2024/02/02/2822821/0/en/GRI-Bio-Announces-Pricing-of-5-5-Million-Public-Offering.html
https://www.globenewswire.com//news-release/2024/01/26/2817930/0/en/GRI-Bio-Announces-Reverse-Stock-Split.html